Purines are ubiquitous endogenous metabolites, and their roles as sign
alling molecules, especially in the case of adenosine and ATP, are wel
l documented. The release of purines is increased when cells are highl
y activated, stressed or damaged, and this is known to have profound e
ffects on various organ systems. Recently, purines like adenosine and
ATP have been shown to be cytotoxic. Current evidence suggests that ad
enosine induces cell death by apoptosis, whereas ATP appears to cause
both necrosis and apoptosis. Apoptosis is an important physiological p
rocess during normal tissue turnover and in the maturation of the immu
ne system, embryogenesis, metamorphosis, endocrine-dependent tissue at
rophy, etc. Recently, many of the key components of the apoptotic cell
death cascade have become unravelled. In particular, proteases belong
ing to the interleukin-1 beta-converting (ICE) enzyme family, also kno
wn as caspases, have been shown to act as an intracellular convergence
point that orchestrates the morphological and biochemical features of
apoptosis. However, little is known about the signalling or the bioch
emical mechanisms of purine-mediated cell death. Adenosine appears to
act through PI purinoceptors, although the subtype involved remains co
ntroversial, whereas ATP may involve both P2X(1) and P2X(7) purinocept
ors. More recent evidence suggests that the intracellular levels of pu
rines, in addition to the cell surface receptor-mediated responses, ma
y also play a critical role by modulating other apoptotic cell death s
ignals. Here, we review our current understanding about purines in med
iating cell death and raise a number of questions as to the possible m
echanisms involved. (C) 1997 Elsevier Science Ltd.